Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 6, 2016
Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease
Dan P Covey, Hannah M Dantrassy, Natalie E Zlebnik, et al.
The European Journal of Neuroscience
|
April 3, 2016
Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids
Dan P Covey, Kendra D Bunner, Douglas R Schuweiler, et al.
Applied Physics Letters
|
August 7, 2013
Characterization of ultrananocrystalline diamond microsensors for <i>in vivo</i> dopamine detection
Prabhu U Arumugam, Hongjun Zeng, Shabnam Siddiqui, et al.
The European Journal of Neuroscience
|
September 16, 2018
Contributions of nucleus accumbens dopamine to cognitive flexibility
Anna K Radke, Adrina Kocharian, Dan P Covey, et al.
Advances in Experimental Medicine and Biology
|
October 14, 2024
Monoacylglycerol Lipase Inhibition Using ABX-1431 Attenuates Cerebral Ischaemia Early After Traumatic Brain Injury
Denis E Bragin, Olga A Bragina, Dan P Covey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 22, 2018
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease
Dan P Covey, Hannah M Dantrassy, Samantha E Yohn, et al.
Nature Communications
|
November 21, 2023
Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction
Miguel Á Luján, Dan P Covey, Reana Young-Morrison, et al.
Journal of Neurotrauma
|
December 1, 2020
Use of Medical Cannabis to Treat Traumatic Brain Injury
Danielle C Hergert, Cidney Robertson-Benta, Veronik Sicard, et al.
Neuron
|
December 8, 2017
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens
Yolanda Mateo, Kari A Johnson, Dan P Covey, et al.
Molecular Psychiatry
|
August 18, 2018
Activation of the mGlu<sub>1</sub> metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M<sub>4</sub> muscarinic receptor allosteric modulators
Samantha E Yohn, Daniel J Foster, Dan P Covey, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
May 6, 2016
Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease
Dan P Covey, Hannah M Dantrassy, Natalie E Zlebnik, et al.
The European Journal of Neuroscience
|
April 3, 2016
Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids
Dan P Covey, Kendra D Bunner, Douglas R Schuweiler, et al.
Applied Physics Letters
|
August 7, 2013
Characterization of ultrananocrystalline diamond microsensors for <i>in vivo</i> dopamine detection
Prabhu U Arumugam, Hongjun Zeng, Shabnam Siddiqui, et al.
The European Journal of Neuroscience
|
September 16, 2018
Contributions of nucleus accumbens dopamine to cognitive flexibility
Anna K Radke, Adrina Kocharian, Dan P Covey, et al.
Advances in Experimental Medicine and Biology
|
October 14, 2024
Monoacylglycerol Lipase Inhibition Using ABX-1431 Attenuates Cerebral Ischaemia Early After Traumatic Brain Injury
Denis E Bragin, Olga A Bragina, Dan P Covey, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 22, 2018
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease
Dan P Covey, Hannah M Dantrassy, Samantha E Yohn, et al.
Nature Communications
|
November 21, 2023
Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction
Miguel Á Luján, Dan P Covey, Reana Young-Morrison, et al.
Journal of Neurotrauma
|
December 1, 2020
Use of Medical Cannabis to Treat Traumatic Brain Injury
Danielle C Hergert, Cidney Robertson-Benta, Veronik Sicard, et al.
Neuron
|
December 8, 2017
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of Dopamine Release in the Nucleus Accumbens
Yolanda Mateo, Kari A Johnson, Dan P Covey, et al.
Molecular Psychiatry
|
August 18, 2018
Activation of the mGlu<sub>1</sub> metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M<sub>4</sub> muscarinic receptor allosteric modulators
Samantha E Yohn, Daniel J Foster, Dan P Covey, et al.
Page
of 3